Medtech Insight RSS Feed - Combination Products

Scrip Asks... What Does 2026 Hold For Biopharma? Part 4: R&D Innovation

Eleanor Malone — Fri, 06 Feb 2026 12:14:39 +0000

Enthusiastic predictions from industry leaders for ongoing progress in obesity, oncology, immunology, neuroscience and more were supported by optimism for the potential of AI and other technological a

Circio’s Vision For Long-Lasting Nucleic Acid Therapeutics

David Wild — Mon, 16 Dec 2024 17:38:31 +0000

The reason Erik Wiklund can so clearly recall the evolution of the science of circular RNA is that he was there from the outset. “In the late 2000s, during my PhD work in molecular biology, Thomas Han

AbbVie Looks To Umoja To Partner On In Vivo CAR-Ts

Alaric DeArment — Thu, 04 Jan 2024 21:59:24 +0000

AbbVie Inc. ’s latest foray into CAR-T cell therapy is a partnership with Umoja Biopharma, Inc. focused on in vivo CAR-T cells, an area a number of companies large and small have explored with mixed

Financing Quarterly Statistics, Q3 2022

Deanna Kamienski|Maureen Riordan — Tue, 01 Nov 2022 09:12:03 +0000

Biopharma Financing Biopharma financings during the third quarter of 2022 totaled $18.1bn from 236 deals. The largest was a $1.39bn royalty sale by Theravance Biopharma to Royalty Pharma , which acqu

Deals Shaping The Medical Industry, October 2019

Deanna Kamienski|Beth Allan|Maureen Riordan|Amanda Micklus — Wed, 23 Oct 2019 12:35:19 +0000

IN VITRO DIAGNOSTICS Mergers & Acquisitions OpGen Inc. Curetis NV Curetis NV and fellow public infectious disease-focused molecular diagnostics firm OpGen Inc. are reverse merging. (Sep.) Curetis

Deal-Making Fires Up To Unlock Checkpoint Inhibitors’ Full Potential

Melanie Senior — Wed, 20 Feb 2019 10:14:34 +0000

Checkpoint inhibitors (CPIs) un-do one of the mechanisms that cancers use to evade the immune system. Their success has proven the concept of using the body’s own defences to fight cancer, firing up t

Deals Shaping The Medical Industry, October 2018

Beth Allan|Deanna Kamienski|Maureen Riordan — Tue, 23 Oct 2018 07:58:39 +0000

IN VITRO DIAGNOSTICS Mergers & Acquisitions Quest Diagnostics Inc. Oxford Immunotec Global PLC Quest Diagnostics Inc. is acquiring Oxford Immunotec Global PLC ’s US laboratory services business.

Deals Shaping The Medical Industry, June 2017

Beth Allan|Deanna Kamienski|Maureen Riordan — Fri, 09 Jun 2017 14:01:15 +0000

IN VITRO DIAGNOSTICS Financings Accelerate Diagnostics Inc. Infectious disease-focused Accelerate Diagnostics Inc. netted $74.6mm through the upsized follow-on offering of 2.75mm common shares pri

Synthetic Biology And The Computerization Of Drug Development

Melanie Senior — Tue, 11 Oct 2016 18:31:12 +0000

Over the last three decades, digital technologies have transformed lifestyles, livelihoods and businesses, creating new wealth, industrial sectors and opportunities. The impact of synthetic biology –

Deals Shaping the Medical Industry, September 2016

Beth Allan|Steven Muntner|Maureen Riordan|Deanna Kamienski — Thu, 15 Sep 2016 15:45:52 +0000

IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Corp. Advanced Cell Diagnostics Inc. Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Dia

Venture Funding Deals, July 2016

Deanna Kamienski|Beth Allan|Amanda Micklus|Steven Muntner|Maureen Riordan — Tue, 05 Jul 2016 12:00:01 +0000

IN VITRO DIAGNOSTICS AccuraGen Inc. AccuraGen raises $40mm through Series B round AccuraGen Inc. (cancer diagnostics) raised $40mm through its Series B round from investors including Junson Ca

Scrip's Rough Guide To CRISPR Gene Editing

Sten Stovall — Tue, 28 Jun 2016 12:01:31 +0000

Gene editing has been a research goal ever since scientists came to understand that DNA carried heritable information. Gene manipulation through recombinant DNA techniques is not editing, unless your

Deals Shaping The Medical Industry, September 2014

Tue, 09 Sep 2014 12:20:06 +0000

IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. Siemens AG Siemens Healthcare Diagnostics Inc. Danaher Corp.’s Beckman Coulter Inc. bought Siemens Healthcare Diagnostics

Deals Shaping The Medical Industry, July/August 2014

Tue, 15 Jul 2014 11:30:00 +0000

IN VITRO DIAGNOSTICS Mergers & Acquisitions Immucor Inc. Organ-I Inc. Immucor Inc. acquired fellow privately held transplant diagnostics company Organ-I Inc. (Jun.) Organ-I spun out of Stanf

Deals Shaping The Medical Industry, March 2014

Tue, 04 Mar 2014 18:00:02 +0000

IN VITRO DIAGNOSTICS Mergers & Acquisitions Becton Dickinson & Co. Alverix Inc. Becton Dickinson & Co. acquired its privately held point-of-care testing partner Alverix Inc. (optoelectronics)

Can Nanotech Be a Game-Changer for In Vitro Diagnostics?

Sat, 01 Nov 2008 04:00:00 +0000

Nanotechnology encompasses a complex aggregation of science and engineering skills, but nanotech-oriented diagnostic instruments are aimed at providing simplicity and speed to users. by Mark L. Ratner